Literature DB >> 4473046

Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes.

I M Goldstein, G Weissmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4473046

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  50 in total

1.  Proceedings. Site of action of an anti-inflammatory fraction from normal human plasma.

Authors:  J K Badcock; A W Ford-Hutchinson; M J Smith
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

Review 2.  Complement in ischemia reperfusion injury.

Authors:  Niels C Riedemann; Peter A Ward
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 3.  Role of granulocytes in immune complex-induced tissue injuries.

Authors:  C G Cochrane
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

Review 4.  Current and future concepts of abdominal sepsis.

Authors:  Klaus Emmanuel; Heike Weighardt; Holger Bartels; Jorg-Rudiger Siewert; Bernhard Holzmann
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

5.  An anti-inflammatory substance in normal human plasma.

Authors:  M J Smith; A W Ford-Hutchinson
Journal:  Agents Actions       Date:  1975-10

6.  Modulation of the inflammatory response by products released from human polymorphonuclear leukocytes during phagocytosis : Generation and inactivation of the chemotactic factor C5a.

Authors:  D G Wright; J I Gallin
Journal:  Inflammation       Date:  1975-03       Impact factor: 4.092

7.  Complement lesions in cell membranes from joint effusions of various types of arthritis.

Authors:  R R Dourmashkin; S Patterson
Journal:  Inflammation       Date:  1976-03       Impact factor: 4.092

Review 8.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Potentiation of C56-initiated lysis by leucocyte cationic proteins, myelin basic proteins and lysine-rich histones.

Authors:  P J Baker; T F Lint; J Siegel; M W Kies; H Gewurz
Journal:  Immunology       Date:  1976-04       Impact factor: 7.397

10.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.